Regenerex Pharma (RGPX) Shares Outstanding (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Shares Outstanding data on file, last reported at $281.8 million in Q3 2025.

• Quarterly Shares Outstanding rose 1.19% year-over-year to $281.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $281.8 million (up 1.19% YoY) and the FY2025 annual result came in at $281.1 million, up 1.02% from the prior year.
• Shares Outstanding steadied at $281.8 million in Q3 2025 per RGPX's latest filing, from $281.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $281.8 million in Q3 2025 and bottomed at $127.1 million in Q2 2021.
• The 5-year median for Shares Outstanding is $277.6 million (2023), against an average of $261.5 million.
• Peak annual rise in Shares Outstanding reached 118.01% in 2021, while the deepest fall reached 0.0% in 2021.
• Tracing RGPX's Shares Outstanding over 5 years: stood at $277.1 million in 2021, then changed by 0.0% to $277.1 million in 2022, then climbed by 0.3% to $277.9 million in 2023, then grew by 0.19% to $278.5 million in 2024, then increased by 1.18% to $281.8 million in 2025.
• Per Business Quant, the three latest RGPX Shares Outstanding figures stand at $281.8 million (Q3 2025), $281.2 million (Q2 2025), and $281.1 million (Q1 2025).

Peer Comparison